author-photo

Eva-Maria Grischke

Heidelberg University

23

Papers

312

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

2018
Show All
- Source
- Cite
- Save
Citations (11)
The PACOVAR-trial: A multicenter phase I trial of pazopanib (GW786034) and metronomic cyclophosphamide in patients with recurrent platinum-resistant ovarian cancer

2016 Geburtshilfe Und Frauenheilkunde
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of 12 weeks neoadjuvant Nab-Paclitaxel combined with Carboplatinum vs. Gemcitabine in triple negative breast cancer: WSG-ADAPT TN randomized phase II trial

2016 Onkologie
Show All
- Source
- Cite
- Save
Citations (3)
Die AGO-OVAR 2.20/PENELOPE Studie – Therapie des platinresistenten Ovarialkarzinoms mit Pertuzumab (P) und Chemotherapie (CT) nach Biomarker-unterstützter Präselektion von Patienten

2014 Geburtshilfe Und Frauenheilkunde
Show All
- Source
- Cite
- Save
Citations (0)
Everolimus und Exemestan - eine innovative Therapieoption für Patientinnen mit fortgeschrittenem HR+, HER2– Mammakarzinom

2014
Show All
- Source
- Cite
- Save
Citations (0)
Trastuzumab single-drug therapy after failure of cytotoxic treatment for metastatic breast cancer.

2010 Onkologie
Show All
- Source
- Cite
- Save
Citations (5)
Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome

2004 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (47)
Intraperitoneal bispecific antibody (HEA125XOKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma

2002 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (51)
Tandem High-Dose Chemotherapy in High-Risk Primary Breast Cancer: A Multivariate Analysis and a Matched-Pair Comparison With Standard-Dose Chemotherapy

2001 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (12)
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients

2001 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (38)